Stock Analysis
LifeStance Health Group, Inc. (LFST) Stock Analysis
LifeStance Health Group, Inc. (LFST) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
LifeStance Health Group, Inc. (LFST) currently has an AIQ Score of 51/100, indicating a neutral setup. Momentum is the strongest factor at 71/100. Value is the weakest current factor at 35/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
LFST at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $12.97 |
| AIQ Score | 51/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $4.89B |
| P/E Ratio | 94.9 |
| Forward P/E | — |
| EPS | $0.06 |
| Revenue TTM | $435.35M |
| Dividend Yield | 0.00% |
| Beta | 1.2 |
| Volume | 7.21M |
| 52-week range | $4.77-$14.15 |
| RSI 14 | 61.79 |
| 50-Day SMA | $11.64 |
| 200-Day SMA | $8.37 |
| Analyst Price Target | $13.50 |
| Next Earnings | Nov 5, 2026 |
LFST
OverviewLFST Stock Analysis Summary
LifeStance Health Group, Inc. (LFST) currently has an AIQ Score of 51/100, indicating a neutral setup. Momentum is the strongest factor at 71/100. Value is the weakest current factor at 35/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, LFST has AIQ Score of 51/100 with Momentum base of 71/100 and fading Value at 35/100. Wait for component alignment before adding exposure.
Momentum (71/100) leads while Value (35/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.23% stock move · LFST classified in Medical - Care Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is LFST Bullish or Bearish Right Now?
LFST currently has a neutral overall setup. Momentum is the strongest factor at 71/100, while Value is weakest at 35/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 71/100.
- - Price is +11.39% above its 50-day SMA.
- - Analyst target implies +4.09% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 4).
- - Value is the current constraint at 35/100.
Current Consensus
LFST's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 6 neutral, and 4 sell votes. LFST's 14-day RSI is 61.79, which places the stock in a constructive momentum range. LFST's beta is 1.2, indicating greater market sensitivity than the broad market.
What Changed in LFST?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the LFST Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
LFST Decision Framework
Public evidence layers, setup checks, and risk context for LifeStance Health Group, Inc..
LifeStance Health Group, Inc. (LFST) Stock Analysis
LifeStance Health Group, Inc. has an AIQ Score of 51/100 in a Neutral regime. Momentum is strongest at 71/100. Beta is 1.2, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | LFST is in a Neutral AIQ regime with score 51/100. |
| Signal Conflict | The primary conflict is that momentum leads at 71/100 while value lags at 35/100. |
| Factor Evidence | Momentum 71/100 · Value 35/100 · Quality 46/100 · Risk 58/100 · Sentiment 50/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 71/100.
Momentum is 71/100 and RSI (14) is 61.8.
LFST is in a Neutral regime at 51/100.
Risk factor is 58/100 with beta 1.2 and annual volatility 53.17%.
Current conflict: momentum leads at 71/100 while value lags at 35/100.
LFST Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
LFST Fundamentals
LFST valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
LFST Technical Analysis
LFST technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
LFST Stock Catalysts
Track LFST earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
LFST Dividend Analysis
LFST dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
LFST Financial Data
LFST revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
LFST Risk Analysis
LFST volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
LFST Stock News
LFST stock news, market tone, recent headlines, and catalyst context.
LFST vs Healthcare Services / Managed Care Peers
Current peer cohort: LFST · LH · MCK · MOH · OSCR. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| LFST Current stock | 51/100 | 35/100 | 71/100 | 58/100 | 1.91 | 53.17% | Current |
| LH Labcorp | 48/100 | 59/100 | 31/100 | 64/100 | 0.51 | 24.09% | LFST vs LH |
| MCK McKesson | 48/100 | 58/100 | 56/100 | 50/100 | 0.74 | 31.32% | LFST vs MCK |
| MOH Molina Healthcare | 46/100 | 50/100 | 54/100 | 57/100 | 0.45 | 53.18% | LFST vs MOH |
| OSCR Oscar Health | 64/100 | 59/100 | 65/100 | 29/100 | 1.03 | 70.62% | LFST vs OSCR |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching LFST
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for LFST
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
LFST Stock FAQ
What is LFST stock price today?
LifeStance Health Group, Inc.'s current stock price is $12.97. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is LFST bullish or bearish right now?
LFST's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is LFST's market cap?
LFST's market cap is $4.89B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is LFST's current P/E ratio?
LFST's current P/E ratio is 94.9 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is LFST's RSI?
LFST's 14-day RSI is 61.79 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is LFST above its 50-day and 200-day moving averages?
LFST is 11.39% from its 50-day SMA and 55.04% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is LFST's next earnings date?
LFST's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does LFST pay a dividend?
LFST's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.